There are 21 papers on VLDL-C in aging research: 3 trials and 7 observational studies in people, 2 in animals, 9 reviews.
21 papers study it29 more mention it2 findings
2 new papers in 30 daysSee all 50 papers on VLDL-C
“each 1 mmol/L increase in cumulative estimated VLDL-C was associated with higher CMM risk (HR = 1.210, P < 0.001)”
- Human trial3
- Humans7
- Animals2
Interventions
1Ashwagandha
downin humans1
1 study
Ashwagandha
downin humans1
Ashwagandha decreases VLDL-C in humans (-76.50 mg/dL).
Human trial40 daysn = 43
Associations
1Cardiometabolic multimorbidity
upin humans1HR 1.21
1 study
Cardiometabolic multimorbidity
upin humans1HR 1.21
VLDL-C is linked with a higher risk of cardiometabolic multimorbidity in humans (CHARLS) (HR = 1.210).
HumansCHARLS
Latest
19 papers in 12 monthsAmerican Heart Journal Plus
Early efficacy of oral lipid lowering therapy in achieving LDL-C targets following acute coronary syndrome: A real-world observational study
Cohort study of 511 peopleAcute coronary syndrome
Journal of Geriatric Cardiology
Sustained estimated VLDL-C exposure is associated with cardiometabolic multimorbidity and foam cell dysfunction: evidence from prospective cohorts and in vitro studies
Cohort study of 4,055 peopleCardiometabolic multimorbidity
Cardiovascular Diabetology Endocrinology Reports
Cardiometabolic outcomes of once-weekly IcoSema in adults with type 2 diabetes: systematic review and meta-analysis of the COMBINE trials
Meta-analysis of randomized trialsType 2 diabetes
Diabetes, Obesity & Metabolism
Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression
Meta-analysis of randomized trialsCagrilintide + semaglutide
Frontiers in Cardiovascular Medicine
Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis
Meta-analysis of randomized trialsProbiotics
National Health Statistics Reports
Comparing Low-density Lipoprotein Cholesterol Population Estimates Using Different Predictive Equations: National Health and Nutrition Examination Survey, 2015-2018
Cross-sectional study of 4,461 peopleBiomarkers
Experimental Gerontology
Lipoprotein metabolism and its impact on life expectancy
AHA Scientific Sessions 2025 Abstract
Evaluating Lipid-Lowering Efficacy Of Obicetrapib: An Updated Meta-Analysis of Clinical Trials
Meta-analysisObicetrapib